With Activist Investors Looming, Genzyme Takes Preventive Steps
This article was originally published in The Pink Sheet Daily
Executive Summary
Mutual cooperation agreement with top institutional investor and hiring of a new head of global product quality may be intended to stave off a potential proxy fight.